SG Americas Securities LLC Lowers Holdings in Clarivate Plc (NYSE:CLVT)

SG Americas Securities LLC decreased its position in Clarivate Plc (NYSE:CLVT) by 86.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,978 shares of the company’s stock after selling 92,930 shares during the quarter. SG Americas Securities LLC’s holdings in Clarivate were worth $139,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Banque Cantonale Vaudoise bought a new stake in Clarivate in the 3rd quarter worth approximately $33,000. Tower Research Capital LLC TRC increased its stake in Clarivate by 201.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,682 shares of the company’s stock worth $45,000 after acquiring an additional 3,129 shares during the last quarter. Macquarie Group Ltd. increased its stake in Clarivate by 40.5% in the 1st quarter. Macquarie Group Ltd. now owns 6,077 shares of the company’s stock worth $57,000 after acquiring an additional 1,753 shares during the last quarter. Forum Financial Management LP bought a new stake in Clarivate in the 3rd quarter worth approximately $81,000. Finally, Penserra Capital Management LLC increased its position in shares of Clarivate by 50.0% during the 1st quarter. Penserra Capital Management LLC now owns 5,322 shares of the company’s stock valued at $89,000 after purchasing an additional 1,774 shares during the last quarter. Institutional investors own 85.72% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Barclays cut their target price on Clarivate from $7.00 to $6.00 and set an “underweight” rating on the stock in a research report on Wednesday, February 28th. Royal Bank of Canada cut their target price on Clarivate from $10.00 to $8.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 28th. Morgan Stanley cut their target price on Clarivate from $9.00 to $8.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 28th. Finally, Oppenheimer dropped their price objective on Clarivate from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Wednesday, February 28th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $8.00.

Clarivate Price Performance

Shares of CLVT stock opened at $6.79 on Wednesday. Clarivate Plc has a twelve month low of $6.07 and a twelve month high of $10.03. The stock has a market capitalization of $4.54 billion, a price-to-earnings ratio of -4.59, a P/E/G ratio of 1.46 and a beta of 1.24. The stock has a fifty day simple moving average of $7.76 and a two-hundred day simple moving average of $7.85. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 1.03.

Clarivate (NYSE:CLVT) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.21 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.21. The firm had revenue of $683.70 million during the quarter, compared to analysts’ expectations of $687.80 million. Clarivate had a positive return on equity of 9.95% and a negative net margin of 34.66%. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 EPS. On average, analysts predict that Clarivate Plc will post 0.61 EPS for the current fiscal year.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.